US EditionPublished • loading... • Updated
Breakthrough antibiotic treatment could ease daily struggles for Crohn’s patients in new discovery
- A researcher from McMaster University has developed enterololin, an antibiotic treatment that targets harmful bacteria for Crohn's patients, using AI.
- This treatment could significantly reduce testing time to six months instead of years.
- Currently, a new patient is diagnosed with Crohn's every 48 minutes in Canada, as reported by Crohn's and Colitis Canada.
- Stokes noted that this application of AI could significantly impact Canadian patients.
Insights by Ground AI
28 Articles
28 Articles
Breakthrough antibiotic treatment could ease daily struggles for Crohn’s patients in new discovery
Researchers from McMaster University and the Massachusetts Institute of Technology have developed a new antibiotic that could change the way doctors treat Crohn’s disease and other forms of inflammatory bowel disease.
·Canada
Read Full Article
AI helps Ont. researcher discover breakthrough antibiotic treatment for bowel disease – 105.9 The Region
HAMILTON — A McMaster University researcher has used AI to develop what could be a breakthrough antibiotic treatment for Crohn’s and inflammatory bowel disease. Jon Stokes, along with his team at McMaster, and their partners at the Massachusetts Institute of Technology, has used AI to isolate a new antibiotic treatment in less than half the time it might normally take. Stokes says developing a new antibiotic normally costs millions of dollars an…
Coverage Details
Total News Sources28
Leaning Left9Leaning Right0Center1Last UpdatedBias Distribution90% Left
Bias Distribution
- 90% of the sources lean Left
90% Left
L 90%
Factuality
To view factuality data please Upgrade to Premium
